As Mirena IUD Lawsuits Gear Up, Yaz and Yasmin Litigation Continues to Weigh on Bayer AG’s Earnings

Bayer AG is facing a growing number of Mirena IUD lawsuits, even as its earnings continue to be impacted by the litigation surrounding its Yaz and Yasmin birth control pills, Bernstein Liebhard LLP reports.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Bernstein Liebhard LLP | Consumer Injury Lawyers
It’s likely the Mirena litigation will grow, as we continue to hear from women who have suffered serious complications, allegedly due to this contraceptive device.

New York, New York (PRWEB) October 31, 2012

The product liability litigation surrounding its Yaz and Yasmin birth control pills continues to weigh on Bayer AG’s earnings, even as the company faces a growing number of Mirena IUD lawsuits in New Jersey Superior Court, Bernstein Liebhard LLP reports. According to Bayer AG’s third quarter earnings report, the company’s net income dropped 17.8% , as it set aside a further 200 million euros for Yaz and Yasmin lawsuits.*

A number of Mirena side effect lawsuits pending in New Jersey allege use of the contraceptive device caused women to suffer uterine perforations and other serious Mirena complications. Court records indicate that Bayer Healthcare Pharmaceuticals is seeking consolidation of the Mirena IUD lawsuits in New Jersey Superior Court, Middlesex County.**

“It’s far too early to tell if Mirena IUD lawsuits will have as great an impact on Bayer as the Yaz and Yasmin litigation. However, it’s likely the Mirena litigation will grow, as we continue to hear from women who have suffered serious complications, allegedly due to this contraceptive device,” says Bernstein Liebhard LLP, a nationwide law firm representing clients who have been injured by dangerous drugs and defective medical devices. The firm is currently offering free and confidential Mirena IUD lawsuit reviews on behalf of women who allegedly suffered serious Mirena injuries.

Mirena IUD Lawsuits
Mirena was approved in 2000 as a contraceptive, and its approval was expanded in 2009 for the treatment of heavy menstrual bleeding for women who desire to use an IUD as contraception. The small, t-shaped, plastic device is inserted into a woman’s uterus by her healthcare provider, and works to prevent pregnancy by releasing a low dose of levonorgestrel (a synthetic progestin hormone) directly into the uterus. The Mirena IUD is designed to stay in place for up to 5 years.***

In 2009, the U.S. Food & Drug Administration (FDA) issued a warning letter to Bayer after finding that its Mirena promotions overstated the efficacy of the device and minimized its risks. Among other things, the FDA took issue with marketing claims touting Mirena’s purported ability to improve a woman’s sex life and help her “look and feel great.”**** According to the FDA, Mirena side effects may include: ectopic pregnancy (a pregnancy in which the fertilized egg grows outside the uterus); intrauterine pregnancy (a pregnancy with Mirena in place); group A streptococcal sepsis; an infection called pelvic inflammatory disease; embedment of the device in the uterine wall; and perforation of the uterine wall or cervix.

Young women who used the Mirena IUD and suffered device migration, uterine perforations or other severe Mirena side effects may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about Mirena side effects, please visit Bernstein Liebhard LLP’s website. Free lawsuit evaluations can be obtained by calling 1-877-779-1414.

*seekingalpha.com/article/962771-bayer-ag-management-discusses-q3-2012-results-earnings-call-transcript
** judiciary.state.nj.us/notices/2012/n120814b.pdf
*** fda.gov/newsevents/newsroom/pressannouncements/2009/ucm184747.htm
****fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM197229.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com